Approvals/TGA/NEXOBRID anacaulase-bcdb 4.85 g powder vial with diluent gel bottle composite pack

Approved

STANDARD

NEXOBRID anacaulase-bcdb 4.85 g powder vial with diluent gel bottle composite pack

Nexo Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: cdb136c9dd9400ac
Product Name: NEXOBRID anacaulase-bcdb 4.85 g powder vial with diluent gel bottle composite pack
Artg Id: 450205
Artg Name: NEXOBRID anacaulase-bcdb 4.85 g powder vial with diluent gel bottle composite pack
Sponsor: Nexo Pharmaceuticals Pty Ltd
Artg Date: 2025-09-15
Registration Type: Medicine
Therapeutic Good Type: Medicines
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

cdb136c9dd9400ac

Type

Standard